Finance

Lists
531335:BOM
Zydus Wellness Ltd
₹466.40
-0.47%
(-2.20) 1D
Nov 11, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531335...
Open
₹476.00
High
₹476.00
Low
₹464.10
Mkt. cap
29.72B
Avg. vol.
15.57K
Volume
9.83K
Dividend
0.26%
Quarterly dividend
₹0.30
Ex-dividend date
Jul 17, 2026
P/E ratio
60.63
52-wk high
₹610.95
52-wk low
₹357.55
EPS
₹7.69
Shares outstanding
39.07M
No. of employees
2K
Open
₹476.00
High
₹476.00
Low
₹464.10
Mkt. cap
29.72B
Avg. vol.
15.57K
Volume
9.83K
Dividend
0.26%
Quarterly dividend
₹0.30
Ex-dividend date
Jul 17, 2026
P/E ratio
60.63
52-wk high
₹610.95
52-wk low
₹357.55
EPS
₹7.69
Shares outstanding
39.07M
No. of employees
2K
News stories
From web sources and news partners
Profile
Zydus Wellness is an Indian consumer goods company, which produces nutrition and skincare products. Headquartered in Ahmedabad, it is a subsidiary of the pharmaceutical company Zydus Lifesciences. Its brands include Glucon-D, Sugar Free, EverYuth, Complan, and Nycil. As of 2021, the company operates three manufacturing plants, one in Gujarat and two in Sikkim. Wikipedia
About Zydus Wellness Ltd
CEOTarun G. Arora
Employees1.68K
Founded1994
Headquarters-
SectorConsumer Staples
IndustryFood
Last report
Nov 3, 2026
Fiscal period
Q2 2027
₹0.16 / ₹0.27
-40.00%miss
Revenue / Est. (INR)
11.27B / 11.09B
+1.59%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
9.65B
14.85B
14.37B
11.27B
Cost of goods sold
3.53B
5.43B
4.93B
4.37B
Cost of revenue
3.53B
5.43B
4.93B
4.37B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.53B
4.47B
3.58B
2.86B
Operating expense
6.07B
7.32B
7.59B
6.61B
Total operating expenses
9.60B
12.75B
12.52B
10.98B
Operating income
48.00M
2.10B
1.85B
281.00M
Other non operating income
8.00M
-71.00M
38.00M
64.00M
EBT including unusual items
-415.00M
1.77B
1.62B
76.00M
EBT excluding unusual items
-349.00M
1.74B
1.62B
76.00M
Income tax expense
-16.00M
153.00M
432.00M
25.00M
Effective tax rate
3.86%
8.63%
26.65%
32.89%
Other operating expenses
2.99B
2.29B
3.44B
3.18B
Net income
-399.00M
1.62B
1.19B
51.00M
Net profit margin
-4.14%
10.91%
8.27%
0.45%
Earnings per share
-1.06
5.09
3.74
0.16
Interest and investment income
-
14.00M
-
-
Interest expense
-412.00M
-356.00M
-263.00M
-272.00M
Net interest expenses
-412.00M
-342.00M
-263.00M
-272.00M
Depreciation and amortization charges
555.00M
553.00M
571.00M
571.00M
EBITDA
112.50M
2.46B
2.20B
852.00M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps